Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1961 Jun 17;1(5241):1705–1711. doi: 10.1136/bmj.1.5241.1705

Progress in the Understanding and Treatment of Diabetes Mellitus*

W J H Butterfield
PMCID: PMC1954342  PMID: 20789157

Full text

PDF
1705

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMIN J., GRANT R. T. Adrenaline release during insulin hypoglycaemia in the rabbit. J Physiol. 1959 Dec;149:228–249. doi: 10.1113/jphysiol.1959.sp006337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BUTTERFIELD J., FRY I. K., HOLLING E. Effects of insulin, tolbutamide and phenethyldiguanidine on peripheral glucose uptake in man. Diabetes. 1958 Nov-Dec;7(6):449–454. doi: 10.2337/diab.7.6.449. [DOI] [PubMed] [Google Scholar]
  3. BUTTERFIELD W. J., CAMP J. L., HARDWICK C., HOLLING H. E. Clinical studies on the hypoglycaemic action of the sulphonylureas. Lancet. 1957 Apr 13;272(6972):753–756. doi: 10.1016/s0140-6736(57)91023-1. [DOI] [PubMed] [Google Scholar]
  4. BUTTERFIELD W. J., FRY I. K., HARDWICK C., HOLLING H. E. Tolbutamide in treatment of diabetes mellitus. Br Med J. 1957 Aug 10;2(5040):325–327. doi: 10.1136/bmj.2.5040.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BUTTERFIELD W. J., HOLLING H. E. Peripheral glucose metabolism in fasting control subjects and diabetic patients. Clin Sci. 1959 May;18:147–174. [PubMed] [Google Scholar]
  6. CREUZFELDT W., FINTER H. Blutzucker und histologische Veränderungen nach D 860 bei normalen Kaninchen. Dtsch Med Wochenschr. 1956 Jun 1;81(22):892–896. [PubMed] [Google Scholar]
  7. DE BODO R. C., ALTSZULER N., DUNN A., STEELE R., ARMSTRONG D. T., BISHOP J. S. Effects of exogenous and endogenous insulin on glucose utilization and production. Ann N Y Acad Sci. 1959 Sep 25;82:431–451. doi: 10.1111/j.1749-6632.1959.tb44924.x. [DOI] [PubMed] [Google Scholar]
  8. FRY I. K., TROUNCE J. R., COOK C. A. Vascular disease in diabetes mellitus: the relation of raised blood protein-bound hexose levels. Diabetes. 1959 May-Jun;8(3):174–178. doi: 10.2337/diab.8.3.174. [DOI] [PubMed] [Google Scholar]
  9. HARDWICK C., BUTTERFIELD W. J., FRY I. K., BRIGGS J. H. Direct measurement of the effect of insulin on the uptake of glucose by peripheral muscles in normal subjects, diabetics and acromegalics. Proc R Soc Med. 1959 Oct;52:807–812. doi: 10.1177/003591575905201002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. JOINER C. L. Rate of clearance of insulin labelled with 131 I from the subcutaneous tissues in normal and diabetic subjects. Lancet. 1959 May 9;1(7080):964–967. doi: 10.1016/s0140-6736(59)91080-3. [DOI] [PubMed] [Google Scholar]
  11. JOPLIN G. F., FRASER R., VALLANCE-OWEN J. Tolbutamide control of diabetes mellitus. Selection of patients and persistence of response. Lancet. 1959 Oct 17;2(7103):582–584. doi: 10.1016/s0140-6736(59)91691-5. [DOI] [PubMed] [Google Scholar]
  12. KRALL L. P., WHITE P., BRADLEY R. F. Clinical use of the biguanides and their role in stabilizing juvenile-type diabetes. Diabetes. 1958 Nov-Dec;7(6):468–477. doi: 10.2337/diab.7.6.468. [DOI] [PubMed] [Google Scholar]
  13. MADISON L. L., COMBES B., ADAMS R., STRICKLAND W. The physiological significance of the secretion of endogenous insulin into the portal circulation. III. Evidence for a direct immediate effect of insulin on the balance of glucose across the liver. J Clin Invest. 1960 Mar;39:507–522. doi: 10.1172/JCI104065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MAHLER R. F. Chemistry of hypoglycaemic substances other than insulin. Br Med Bull. 1960 Sep;16:250–254. doi: 10.1093/oxfordjournals.bmb.a069845. [DOI] [PubMed] [Google Scholar]
  15. MAHLER R. F. Chemistry of hypoglycaemic substances other than insulin. Br Med Bull. 1960 Sep;16:250–254. doi: 10.1093/oxfordjournals.bmb.a069845. [DOI] [PubMed] [Google Scholar]
  16. MAHLER R., SHOEMAKER W. C., ASHMORE J. Hepatic action of insulin. Ann N Y Acad Sci. 1959 Sep 25;82:452–459. doi: 10.1111/j.1749-6632.1959.tb44925.x. [DOI] [PubMed] [Google Scholar]
  17. MOLONEY P. J., COVAL M. Antigenicity of insulin: diabetes induced by specific antibodies. Biochem J. 1955 Feb;59(2):179–185. doi: 10.1042/bj0590179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. NABARRO J. D., BECK J. C., STOWERS J. M. Fructose in the treatment of severe diabetic ketosis. Lancet. 1955 Dec 17;269(6903):1271–1274. doi: 10.1016/s0140-6736(55)93056-7. [DOI] [PubMed] [Google Scholar]
  20. REID J., MACDOUGALL A. I., ANDREWS M. M. Aspirin and diabetes mellitus. Br Med J. 1957 Nov 9;2(5053):1071–1074. doi: 10.1136/bmj.2.5053.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. THOMPSON R. H., BUTTERFIELD W. J., FRY I. K. Pyruvate metabolism in diabetic neuropathy. Proc R Soc Med. 1960 Feb;53:143–146. doi: 10.1177/003591576005300212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. WALKER R. S., LINTON A. L. Phenethyldiguanide: a dangerous side-effect. Br Med J. 1959 Nov 14;2(5158):1005–1006. doi: 10.1136/bmj.2.5158.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. YALOW R. S., BERSON S. A. Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic. Diabetes. 1960 Jul-Aug;9:254–260. doi: 10.2337/diab.9.4.254. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES